Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Upcoming patient data

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Feb 19, 2022 11:05am

288 Views

Post# 34444815

RE:RE:RE:RE:RE:Upcoming patient data

Fingers crossed. It would feel wonderful to climb closer to $1. Or at least past 50 cents. I don't know what it will take for the share price to take off if data so far has not done it. Perhaps we will simply have to wait for that BTD or perhaps some kind of beneficial j/v out of the blue. But solid data will of course make the wait a bit easier. Not long to go now.

<< Previous

Bullboard Posts

Next >>

This AI stock is disrupting the event tickets monopoly